The pharmaceutical sector is experiencing a transformative shift as major industry players redirect significant investment toward precision medicine, marking one of the most important advances in drug development in the past several decades. This fundamental repositioning reflects growing recognition that conventional standardized therapies often overlook the distinct biological, environmental, and behavioral variables that affect individual…